Hypertension
Conditions
Brief summary
Primary objective: to characterize hypertensive patients treated for at least 1 month with Telmisartan (alone or in combination with other drugs) in order to define the beneficiary population (those actually receiving the treatment). Secondary objectives: * to describe the patients' blood pressure values (when self-monitored) and satisfaction with the treatment (ease of use, efficacy, safety) on the basis of a patient self-questionnaire, filled out 4 weeks after consultation. * to compare the characteristics of the beneficiary population to those of the initial target population defined in the SPC (summary of product characteristics) for Telmisartan
Interventions
DRUGTelmisartan
Sponsors
Boehringer Ingelheim
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
21 Years to 94 Years
Healthy volunteers
No
Inclusion criteria
* Hypertensive patients treated with Telmisartan for at least one month, consulting a medical practitioner (for whatever reason)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Characteristics of hypertensive patients | Baseline, after 1 month of treatment | Questionnaire to determine the beneficiary population |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in blood pressure | Up to 1 month | Self-monitored by patient |
| Evaluation of patients satisfaction with treatment | Up to 1 month | Based on a patient 6-point self-questionnaire |
Outcome results
None listed